Respiratory

The BCG vaccine decreased the overall risk of new respiratory infections in elderly adults, according to the study results.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” on Tuesday, October 13, 2020 at 6 PM EDT.

Investigators reported that, compared with chemotherapy, atezolizumab monotherapy was superior in overall survival and progression-free survival in patients with NSCLC.

Tocilizumab (Actemra; Genentech) reduced the likelihood of needing mechanical ventilation in hospitalized patients with COVID-19 associated pneumonia.

Perrigo has issued a voluntary recall of all unexpired albuterol sulfate inhalation aerosol to the retail level.

A new report illuminates the similarities and differences between COVID-19 and seasonal influenza.

Teva’s 2 digital inhalers for patients with asthma provide insight into objective inhaler use data.

Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.

Early data from a phase 3 trial showed that baricitinib combined with remdesivir improved recovery in patients hospitalized with COVID-19 compared with remdesivir alone.

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta; GlaxoSmithKline) is indicated for the treatment of asthma in patients aged 18 years and older.

Pharmacists can play an important role in pneumonia management and prevention.

Three scientists discuss the global race for a COVID-19 vaccine.

A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.

Approval was based on trials that reported significantly reduced exacerbation rates compared with dual-combination therapies.

Some patients affected by COVID-19 may be concerned about hyposmia (reduced ability to smell) or anosmia (loss of smell) that they experience after contracting the virus.

Pfizer and BioNTech SE announced that 2 of its most successful vaccine candidates received Fast Track designation from the FDA, opening the avenue for speedy development.

“Pharmacists should ensure that patients have a written asthma action plan.”

The therapy will also be available for individuals with asthma and suspected COVID-19 infection.

Moderna announced interim analysis results of its investigational COVID-19 vaccine candidate, mRNA-1273, from an ongoing phase 1 study.

The FDA has granted emergency use authorization to an additional combination diagnostic test for influenza and COVID-19.

In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

The CDC released an updated vaccination guidance on administering routine vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.